Detalles de la búsqueda
1.
Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology.
Neuroendocrinology;
111(1-2): 158-169, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32015233
2.
Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors.
BMC Cancer;
20(1): 1186, 2020 Dec 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33272243
3.
MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial.
Br J Cancer;
120(4): 387-397, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30739911
4.
Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report.
BMC Pulm Med;
19(1): 12, 2019 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30634951
5.
EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice.
Eur Respir J;
50(2)2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28798090
6.
Bevacizumab in advanced lung cancer: state of the art.
Future Oncol;
13(28): 2515-2535, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28812378
7.
A review of bevacizumab in the treatment of malignant pleural mesothelioma.
Future Oncol;
13(28): 2537-2546, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29086616
8.
Assessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip.
Cell Rep Med;
5(5): 101549, 2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38703767
9.
VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial.
Lung Cancer;
182: 107287, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37393757
10.
Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study.
Clin Lung Cancer;
24(1): 1-10, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36180314
11.
Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti-Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer.
J Thorac Oncol;
18(10): 1408-1415, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37217096
12.
Lazarus syndrome in nonsmall cell lung cancer patients with poor performance status and major leukocytosis following nivolumab treatment.
Eur Respir J;
50(1)2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28751414
13.
Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP.
Target Oncol;
17(4): 407-431, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35906513
14.
Grade 3-4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study.
Cancers (Basel);
14(16)2022 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36010872
15.
Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer.
Cells;
11(6)2022 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35326466
16.
Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment.
Ther Adv Med Oncol;
13: 17588359211061956, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34917175
17.
Poor performance status patient with long-lasting major response to pembrolizumab in advanced non-small-cell lung cancer with coexisting POLE mutation and deficient mismatch repair pathway.
Lung Cancer;
160: 28-31, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34371300
18.
Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trial.
Lung Cancer;
158: 146-150, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34217967
19.
EGFR Exon 20 Insertion in Metastatic Non-Small-Cell Lung Cancer: Survival and Clinical Efficacy of EGFR Tyrosine-Kinase Inhibitor and Chemotherapy.
Cancers (Basel);
13(20)2021 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34680280
20.
A new KIF5B-ERBB4 gene fusion in a lung adenocarcinoma patient.
ERJ Open Res;
7(1)2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33816604